SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Michael Andrew Chambers bought $3.7M of Sarepta Therapeutics, Inc.
Bought$3,701,067
$106.15Price
34,867Shares
+19%Stake
What SRPT did for a copier
- $1,000 copied at Fri, Aug 11 open, $108.02
- $1,062
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Sep 25 close.
Michael Andrew Chambers's record
4 other buys with 3 months of prices since 2022: on average −7.9% against the S&P 500, and 2 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Aug 10. Filed Fri, Aug 11, 7:40 AM ET, before the open. Returns use the Aug 11 open and the Sep 25 close. Not investment advice.